Elegant studies on T47D and MCF-7 breast cancer cell lines with PNA-peptide conjugates targeting human progesterone receptor gene isoforms A and B revealed the extent to which expression of progesterone receptor protein was attenuated [25]. The gene discussed is PGR; the disease is breast carcinoma.